August 1972

Follow-Up Studies in Neonatal Inclusion Conjunctivitis

Author Affiliations

San Diego,Calif; Dallas
From the Department of Pediatrics and the Clinical Investigation Center, US Naval Hospital, San Diego, Calif (CDR Goscienski) and the Department of Ophthalmology, University of Texas, Southwestern Medical School at Dallas (Dr. Sexton).

Am J Dis Child. 1972;124(2):180-182. doi:10.1001/archpedi.1972.02110140030003

Seven infants with documented neonatal inclusion conjunctivitis were studied at 7 to 11 months of age. All had received topical tetracycline or sulfacetamide therapy for 10 to 14 days at the time of initial diagnosis. None had recurrence of disease or persistent clinical symptoms. At follow-up, inflammatory cells were present in conjunctival scrapings but Giemsa and indirect fluorescent antibody stains revealed no inclusions. No child had conjunctival scars but two had minimal scarring of the corneal limbus as described in previous investigations on inclusion conjunctivitis.